NexgenRX Inc. (NXG) — Capital Reinvestment Ratio
NexgenRX Inc. (NXG) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow (CA$880.82K) in capital expenditures (CA$18.07K). Check NXG intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
NexgenRX Inc. Capital Reinvestment Ratio (2013–2024)
This chart tracks NexgenRX Inc.'s Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see NexgenRX Inc. (NXG) cash conversion ratio.
Annual Capital Reinvestment Ratio for NexgenRX Inc. (2013–2024)
Year-by-year Capital Reinvestment Ratio for NexgenRX Inc. from 2013 to 2024. See NXG free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.28x | CA$1.15 Million | CA$317.69K | ▲ +42.0% |
| 2023 | 0.19x | CA$1.28 Million | CA$248.41K | ▼ -46.7% |
| 2022 | 0.36x | CA$1.07 Million | CA$388.81K | ▲ +1002.2% |
| 2021 | 0.03x | CA$3.82 Million | CA$126.55K | ▼ -27.3% |
| 2020 | 0.05x | CA$2.65 Million | CA$120.74K | ▼ -6.3% |
| 2019 | 0.05x | CA$1.05 Million | CA$50.78K | ▼ -93.3% |
| 2016 | 0.72x | CA$490.96K | CA$355.00K | ▲ +1084.7% |
| 2013 | 0.06x | CA$774.08K | CA$47.24K | — |